(Adds details in paragraphs 2-4) Nov 16 (Reuters) – Johnson & Johnson said on Monday it had agreed to buy Texas-based biotech Ollin Biosciences, expanding its pipeline of eye disease therapies.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 16 (Reuters) - Tyson Foods forecast a steeper-than-expected annual revenue decline on Monday as…
By Jun Yuan Yong and Eduardo Baptista Nov 16 (Reuters) - Singapore's government said on…
Mumbai (Maharashtra) [India], November 16: Samsonite, the global leader in travel, luggage and mobility solutions,…
Nov 16 (Reuters) - Zhuhai Kles Technology Co Ltd : * SAYS BOARD ELECTED YU…
By Javi West Larrañaga and Gregor Stuart Hunter GDANSK, Nov 16 (Reuters) - The dollar…
Nov 16 (Reuters) - US President Donald Trump's reported trades this year suggest he held…